Ovarian cancer and lower limb lymphedema.
Identifieur interne : 002894 ( Ncbi/Merge ); précédent : 002893; suivant : 002895Ovarian cancer and lower limb lymphedema.
Auteurs : Suzy Lockwood-Rayermann [États-Unis]Source :
- Oncology (Williston Park, N.Y.) [ 0890-9091 ] ; 2007.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Adénocarcinome (anatomopathologie), Cisplatine (administration et posologie), Femelle, Humains, Lymphoedème (), Lymphoedème (anatomopathologie), Lymphoedème (soins infirmiers), Membre inférieur (anatomopathologie), Paclitaxel (administration et posologie), Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Radiographie, Résultat thérapeutique, Stade de la tumeur, Tumeurs de l'ovaire (), Tumeurs de l'ovaire (anatomopathologie), Tumeurs de l'ovaire (imagerie diagnostique), Tumeurs de l'ovaire (traitement médicamenteux), Échographie.
- MESH :
- administration et posologie : Cisplatine, Paclitaxel.
- anatomopathologie : Adénocarcinome, Lymphoedème, Membre inférieur, Tumeurs de l'ovaire.
- imagerie diagnostique : Tumeurs de l'ovaire.
- soins infirmiers : Lymphoedème.
- traitement médicamenteux : Tumeurs de l'ovaire.
- usage thérapeutique : Protocoles de polychimiothérapie antinéoplasique.
- Adulte d'âge moyen, Femelle, Humains, Lymphoedème, Radiographie, Résultat thérapeutique, Stade de la tumeur, Tumeurs de l'ovaire, Échographie.
English descriptors
- KwdEn :
- Adenocarcinoma (pathology), Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Cisplatin (administration & dosage), Female, Humans, Lower Extremity (pathology), Lymphedema (complications), Lymphedema (nursing), Lymphedema (pathology), Lymphedema (surgery), Middle Aged, Neoplasm Staging, Ovarian Neoplasms (complications), Ovarian Neoplasms (diagnostic imaging), Ovarian Neoplasms (drug therapy), Ovarian Neoplasms (pathology), Ovarian Neoplasms (surgery), Paclitaxel (administration & dosage), Radiography, Treatment Outcome, Ultrasonography.
- MESH :
- chemical , administration & dosage : Cisplatin, Paclitaxel.
- complications : Lymphedema, Ovarian Neoplasms.
- diagnostic imaging : Ovarian Neoplasms.
- drug therapy : Ovarian Neoplasms.
- nursing : Lymphedema.
- pathology : Adenocarcinoma, Lower Extremity, Lymphedema, Ovarian Neoplasms.
- surgery : Lymphedema, Ovarian Neoplasms.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- Female, Humans, Middle Aged, Neoplasm Staging, Radiography, Treatment Outcome, Ultrasonography.
PubMed: 17844892
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 003529
- to stream PubMed, to step Curation: 003529
- to stream PubMed, to step Checkpoint: 003529
Links to Exploration step
pubmed:17844892Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Ovarian cancer and lower limb lymphedema.</title>
<author><name sortKey="Lockwood Rayermann, Suzy" sort="Lockwood Rayermann, Suzy" uniqKey="Lockwood Rayermann S" first="Suzy" last="Lockwood-Rayermann">Suzy Lockwood-Rayermann</name>
<affiliation wicri:level="2"><nlm:affiliation>Texas Christian University, Fort Worth, Texas, USA. s.lockwood@tcu.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Texas Christian University, Fort Worth, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2007">2007</date>
<idno type="RBID">pubmed:17844892</idno>
<idno type="pmid">17844892</idno>
<idno type="wicri:Area/PubMed/Corpus">003529</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003529</idno>
<idno type="wicri:Area/PubMed/Curation">003529</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003529</idno>
<idno type="wicri:Area/PubMed/Checkpoint">003529</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">003529</idno>
<idno type="wicri:Area/Ncbi/Merge">002894</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Ovarian cancer and lower limb lymphedema.</title>
<author><name sortKey="Lockwood Rayermann, Suzy" sort="Lockwood Rayermann, Suzy" uniqKey="Lockwood Rayermann S" first="Suzy" last="Lockwood-Rayermann">Suzy Lockwood-Rayermann</name>
<affiliation wicri:level="2"><nlm:affiliation>Texas Christian University, Fort Worth, Texas, USA. s.lockwood@tcu.edu</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Texas Christian University, Fort Worth, Texas</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Oncology (Williston Park, N.Y.)</title>
<idno type="ISSN">0890-9091</idno>
<imprint><date when="2007" type="published">2007</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (pathology)</term>
<term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term>
<term>Cisplatin (administration & dosage)</term>
<term>Female</term>
<term>Humans</term>
<term>Lower Extremity (pathology)</term>
<term>Lymphedema (complications)</term>
<term>Lymphedema (nursing)</term>
<term>Lymphedema (pathology)</term>
<term>Lymphedema (surgery)</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Ovarian Neoplasms (complications)</term>
<term>Ovarian Neoplasms (diagnostic imaging)</term>
<term>Ovarian Neoplasms (drug therapy)</term>
<term>Ovarian Neoplasms (pathology)</term>
<term>Ovarian Neoplasms (surgery)</term>
<term>Paclitaxel (administration & dosage)</term>
<term>Radiography</term>
<term>Treatment Outcome</term>
<term>Ultrasonography</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Adénocarcinome (anatomopathologie)</term>
<term>Cisplatine (administration et posologie)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (anatomopathologie)</term>
<term>Lymphoedème (soins infirmiers)</term>
<term>Membre inférieur (anatomopathologie)</term>
<term>Paclitaxel (administration et posologie)</term>
<term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term>
<term>Radiographie</term>
<term>Résultat thérapeutique</term>
<term>Stade de la tumeur</term>
<term>Tumeurs de l'ovaire ()</term>
<term>Tumeurs de l'ovaire (anatomopathologie)</term>
<term>Tumeurs de l'ovaire (imagerie diagnostique)</term>
<term>Tumeurs de l'ovaire (traitement médicamenteux)</term>
<term>Échographie</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cisplatin</term>
<term>Paclitaxel</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Cisplatine</term>
<term>Paclitaxel</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Adénocarcinome</term>
<term>Lymphoedème</term>
<term>Membre inférieur</term>
<term>Tumeurs de l'ovaire</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Lymphedema</term>
<term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Tumeurs de l'ovaire</term>
</keywords>
<keywords scheme="MESH" qualifier="nursing" xml:lang="en"><term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma</term>
<term>Lower Extremity</term>
<term>Lymphedema</term>
<term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="soins infirmiers" xml:lang="fr"><term>Lymphoedème</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Lymphedema</term>
<term>Ovarian Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs de l'ovaire</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Neoplasm Staging</term>
<term>Radiography</term>
<term>Treatment Outcome</term>
<term>Ultrasonography</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphoedème</term>
<term>Radiographie</term>
<term>Résultat thérapeutique</term>
<term>Stade de la tumeur</term>
<term>Tumeurs de l'ovaire</term>
<term>Échographie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17844892</PMID>
<DateCreated><Year>2007</Year>
<Month>09</Month>
<Day>11</Day>
</DateCreated>
<DateCompleted><Year>2007</Year>
<Month>10</Month>
<Day>18</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>11</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0890-9091</ISSN>
<JournalIssue CitedMedium="Print"><Volume>21</Volume>
<Issue>8 Suppl</Issue>
<PubDate><Year>2007</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Oncology (Williston Park, N.Y.)</Title>
<ISOAbbreviation>Oncology (Williston Park, N.Y.)</ISOAbbreviation>
</Journal>
<ArticleTitle>Ovarian cancer and lower limb lymphedema.</ArticleTitle>
<Pagination><MedlinePgn>20-2</MedlinePgn>
</Pagination>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lockwood-Rayermann</LastName>
<ForeName>Suzy</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Texas Christian University, Fort Worth, Texas, USA. s.lockwood@tcu.edu</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Oncology (Williston Park)</MedlineTA>
<NlmUniqueID>8712059</NlmUniqueID>
<ISSNLinking>0890-9091</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>P88XT4IS4D</RegistryNumber>
<NameOfSubstance UI="D017239">Paclitaxel</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber>
<NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D035002" MajorTopicYN="N">Lower Extremity</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008209" MajorTopicYN="Y">Lymphedema</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000451" MajorTopicYN="N">nursing</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010051" MajorTopicYN="N">Ovarian Neoplasms</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017239" MajorTopicYN="N">Paclitaxel</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011859" MajorTopicYN="N">Radiography</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2007</Year>
<Month>10</Month>
<Day>19</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>9</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">17844892</ArticleId>
<ArticleId IdType="pii">169246</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Texas</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Texas"><name sortKey="Lockwood Rayermann, Suzy" sort="Lockwood Rayermann, Suzy" uniqKey="Lockwood Rayermann S" first="Suzy" last="Lockwood-Rayermann">Suzy Lockwood-Rayermann</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002894 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 002894 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:17844892 |texte= Ovarian cancer and lower limb lymphedema. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:17844892" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
This area was generated with Dilib version V0.6.31. |